Hikma Pharmaceuticals

Hikma Pharmaceuticals plc is a British multinational pharmaceutical company headquartered in London, UK, specialising in the development, manufacture, and marketing of generic and in-licensed pharmaceutical products.

Founded in 1978 by Samih Darwazah in Amman, Jordan, Hikma has grown over the past 45 years into a global entity committed to making high-quality medicines accessible to those who need them.

The company's operations span North America, the Middle East and North Africa (MENA), and Europe, focusing on providing better health within reach every day.

Key Products and Services:

• Injectable Medicines: Hikma offers a broad range of injectable generic and branded products, serving hospitals and clinics worldwide.
• Oral and Inhalable Generics: The company develops and manufactures oral and inhalable generic medicines across various therapeutic categories, including cardiovascular, diabetes, central nervous system, oncology, dermatology, and respiratory systems.
• Contract Manufacturing: Hikma provides contract manufacturing services, leveraging its extensive manufacturing capabilities to produce high-quality medicines for other pharmaceutical companies.
• In-Licensed Products: The company markets a range of in-licensed pharmaceutical products, expanding its portfolio to meet diverse patient needs.

Hikma's commitment to quality and accessibility has established it as a trusted partner in the global pharmaceutical industry, dedicated to improving health outcomes by ensuring the availability of essential medicines.